
HELP
Healthcare · Biotechnology · $648.0M market cap
$8.87+0.01 (+0.1%)Nov 13, 4:22 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +6.1% over 90 days · 30-day revisions 1 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Before the open | -1.01 | -2.01 | -99.0% |
| Aug 14, 2026 | Before the open | -0.80 | -0.91 | -13.8% |
| Jun 29, 2026 | Before the open | -1.04 | -1.02 | +1.9% |
| Feb 13, 2026 | Before the open | -0.98 | -1.36 | -38.8% |
| Nov 13, 2025 | Before the open | -1.33 | -1.65 | -24.1% |
| Jun 30, 2025 | After the close | -1.23 | -1.46 | -18.7% |
| Feb 10, 2025 | After the close | -1.57 | -0.53 | +66.2% |
| Nov 13, 2024 | Before the open | -0.91 | -2.86 | -214.3% |
| Aug 8, 2024 | Before the open | -1.33 | -0.76 | +42.9% |
| Jun 25, 2024 | Time not confirmed | — | -0.79 | — |
| Feb 14, 2024 | Before the open | -1.37 | -3.42 | -149.6% |
| Nov 13, 2023 | After the close | -1.77 | -1.90 | -7.3% |
| Aug 14, 2023 | Before the open | -2.13 |
Helus Pharma Inc. operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions. It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder; and HLP004, a deuterated N, N-dimethyltryptamine, which is in phase 2 clinical trial for treating generalized anxiety disorders. The…
| -2.66 |
| -24.9% |
| Jun 28, 2023 | Time not confirmed | — | -1.97 | — |
| Feb 14, 2023 | Before the open | -2.66 | -2.28 | +14.3% |
| Nov 14, 2022 | After the close | -2.85 | -2.09 | +26.7% |
| Aug 9, 2022 | Time not confirmed | — | -2.21 | — |
| Jun 22, 2022 | Before the open | -3.04 | -3.65 | -20.1% |
| Feb 10, 2022 | Before the open | -3.32 | -3.65 | -9.9% |
| Nov 15, 2021 | Before the open | -3.17 | -3.89 | -22.7% |
| Aug 13, 2021 | After the close | -1.77 | -3.40 | -92.1% |
| Jun 28, 2021 | Time not confirmed | — | -2.75 | — |
| Feb 15, 2021 | After the close | -0.76 | -3.80 | -400.0% |